|
|
|
<br>Modafinil, a wakefulness-selling agent, has garnered important consideration since its approval by the FDA in 1998 for the remedy of narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Through the years, it has additionally gained popularity as a cognitive enhancer, often referred to as a "good drug." With the rise of online pharmacies, the availability of generic modafinil has increased, prompting a need for a detailed examination of its implications, efficacy, safety, and the moral considerations surrounding its use. |